NeuroX1 Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series C

  • Investors
  • 7

NeuroX1 General Information

Description

Developer of a computational neuroscience and drug discovery engine designed to identify degenerative disorders of the brain. The company's platform identifies drivers of disease and generative chemistry to produce compounds for those diseases, primarily neurodegenerative, and uses data analytics to design drugs, screen molecules in silicon, and identify small molecules most likely to succeed in clinical trials, enabling the healthcare sector to improve novel disease identification.

Contact Information

Website
www.neurox1.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2205 North Lamar Boulevard
  • Unit 223
  • Austin, TX 78705
  • United States
+1 (512)
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • 2205 North Lamar Boulevard
  • Unit 223
  • Austin, TX 78705
  • United States
+1 (512)

NeuroX1 Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroX1 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 04-Jun-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator 14-Mar-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
2. Seed Round 03-Mar-2023 $500K $1.84M Completed Pre-Clinical Trials
1. Seed Round 31-Dec-2021 $1.34M $1.34M Completed Pre-Clinical Trials
To view NeuroX1’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NeuroX1 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a computational neuroscience and drug discovery engine designed to identify degenerative disorders of the b
Drug Discovery
Austin, TX
4 As of 2025

San Francisco, CA
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroX1 Competitors (7)

One of NeuroX1’s 7 competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Numerion Labs Venture Capital-Backed San Francisco, CA
Voyager Therapeutics Formerly VC-backed Lexington, MA
insitro Venture Capital-Backed South San Francisco, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
InSilico Medicine Cayman Formerly VC-backed Hong Kong, Hong Kong
You’re viewing 5 of 7 competitors. Get the full list »

NeuroX1 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroX1 Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Techstars Accelerator/Incubator Minority
Next Sequence Accelerator/Incubator
Capital Factory Accelerator/Incubator Minority
Drive Capital Venture Capital Minority
Syntax Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

NeuroX1 FAQs

  • When was NeuroX1 founded?

    NeuroX1 was founded in 2021.

  • Where is NeuroX1 headquartered?

    NeuroX1 is headquartered in Austin, TX.

  • What is the size of NeuroX1?

    NeuroX1 has 4 total employees.

  • What industry is NeuroX1 in?

    NeuroX1’s primary industry is Drug Discovery.

  • Is NeuroX1 a private or public company?

    NeuroX1 is a Private company.

  • What is NeuroX1’s current revenue?

    The current revenue for NeuroX1 is .

  • How much funding has NeuroX1 raised over time?

    NeuroX1 has raised $1.96M.

  • Who are NeuroX1’s investors?

    Techstars, Next Sequence, Capital Factory, Drive Capital, and Syntax Ventures are 5 of 7 investors who have invested in NeuroX1.

  • Who are NeuroX1’s competitors?

    Numerion Labs, Voyager Therapeutics, insitro, Exscientia, and InSilico Medicine Cayman are some of the 7 competitors of NeuroX1.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process